N-Methyl-1,3,4-thiadiazol-2-amine

Catalog No.: 
ACXGTD748
CAS No.: 
38490-45-8
Molecular Formula: 
C3H5N3S
Molecular Weight: 
115.16
N-Methyl-1,3,4-thiadiazol-2-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%
250mg95%
1g95%
5g95%

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-Methyl-1,3,4-thiadiazol-2-amine
IUPAC NameN-methyl-1,3,4-thiadiazol-2-amine
MDL No.MFCD00829967
Molecular FormulaC3H5N3S
Molecular Weight115.16
SMILESCNC1=NN=CS1
InChI KeyXORXZRQNXQSDQG-UHFFFAOYSA-N
SynonymN-Methyl-1,3,4-thiadiazol-2-aMine;N-Methyl-1,3,4-Thiadiazol-2-Amine(WX607061);1,3,4-Thiadiazol-2-amine, N-methyl-;2-(Methylamino)-1,3,4-thiadiazole
CAS No.38490-45-8
PubChem CID12229991

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACXGTD748 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACGIKN469 route compound structure diagram
    ACGIKN46952819-57-5In Stock
  4. Then
  5. ACXGTD748 route product structure diagram
    ACXGTD74838490-45-8In Stock
Inquiry

2. ACXGTD748 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNYGQ167 route compound structure diagram
    ACNYGQ16761929-24-6In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXGTD748 route product structure diagram
    ACXGTD74838490-45-8In Stock
Inquiry

3. ACXGTD748 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXGTD748 route product structure diagram
    ACXGTD74838490-45-8In Stock
Inquiry

Comments (0)